4th Jan 2021 19:05
Smith & Nephew PLC - London-based medical technology business - Completes acquisition of Extremity Orthopaedics business of Integra LifeSciences Holdings Corp for USD240 million.
"We are excited to secure this established global business in the rapidly growing extremities segment. Its portfolio, specialised sales channel and product pipeline all strengthen our business and we look forward to welcoming our new colleagues to Smith & Nephew," says Skip Kiil, president of Global Orthopaedics at S&N.
Current stock price: 1570 pence
Year-to-date change: up 4.0%
By Arvind Bhunjun; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Smith & Nephew